de Zeeuw D - Search Results

1

The effect of ramipril and telmisartan on serum potassium and its association with cardiovascular and renal events: results from the ONTARGET trial.

Heerspink HJ, Gao P, de Zeeuw D, Clase C, Dagenais GR, Sleight P, Lonn E, Teo KT, Yusuf S, Mann JF. Heerspink HJ, et al. Among authors: de zeeuw d. Eur J Prev Cardiol. 2014 Mar;21(3):299-309. doi: 10.1177/2047487313510678. Epub 2013 Nov 4. Eur J Prev Cardiol. 2014. PMID: 24191305 Clinical Trial.

2

Optimal blood pressure control and antihypertensive regimens in hypertensive renal disease: the potential of exploring the mechanisms of response variability.

Kocks MJ, de Zeeuw D, Navis GJ. Kocks MJ, et al. Among authors: de zeeuw d. Curr Opin Nephrol Hypertens. 2002 Mar;11(2):135-40. doi: 10.1097/00041552-200203000-00002. Curr Opin Nephrol Hypertens. 2002. PMID: 11856904 Review.

3

Dual renin-angiotensin system blockade at optimal doses for proteinuria.

Laverman GD, Navis G, Henning RH, de Jong PE, de Zeeuw D. Laverman GD, et al. Among authors: de jong pe, de zeeuw d. Kidney Int. 2002 Sep;62(3):1020-5. doi: 10.1046/j.1523-1755.2002.00536.x. Kidney Int. 2002. PMID: 12164886 Free article. Clinical Trial.

4

Renal function as a predictor of prognosis in chronic heart failure.

Hillege H, Van Gilst W, de Zeeuw D, van Veldhuisen DJ. Hillege H, et al. Among authors: de zeeuw d. Heart Fail Monit. 2002;2(3):78-84. Heart Fail Monit. 2002. PMID: 12634888 Review.

5

Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy.

de Zeeuw D, Remuzzi G, Parving HH, Keane WF, Zhang Z, Shahinfar S, Snapinn S, Cooper ME, Mitch WE, Brenner BM. de Zeeuw D, et al. Circulation. 2004 Aug 24;110(8):921-7. doi: 10.1161/01.CIR.0000139860.33974.28. Epub 2004 Aug 9. Circulation. 2004. PMID: 15302780 Clinical Trial.

6

Does comorbidity explain trends in prescribing of newer antihypertensive agents?

Greving JP, Denig P, van der Veen WJ, Beltman FW, Sturkenboom MC, de Zeeuw D, Haaijer-Ruskamp FM. Greving JP, et al. Among authors: de zeeuw d. J Hypertens. 2004 Nov;22(11):2209-15. doi: 10.1097/00004872-200411000-00025. J Hypertens. 2004. PMID: 15480107

7

Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria.

Asselbergs FW, Diercks GF, Hillege HL, van Boven AJ, Janssen WM, Voors AA, de Zeeuw D, de Jong PE, van Veldhuisen DJ, van Gilst WH; Prevention of Renal and Vascular Endstage Disease Intervention Trial (PREVEND IT) Investigators. Asselbergs FW, et al. Among authors: de jong pe, de zeeuw d. Circulation. 2004 Nov 2;110(18):2809-16. doi: 10.1161/01.CIR.0000146378.65439.7A. Epub 2004 Oct 18. Circulation. 2004. PMID: 15492322 Clinical Trial.

8

Should albuminuria be a therapeutic target in patients with hypertension and diabetes?

de Zeeuw D. de Zeeuw D. Am J Hypertens. 2004 Nov;17(11 Pt 2):11S-15S; quiz A2-4. doi: 10.1016/j.amjhyper.2004.08.005. Am J Hypertens. 2004. PMID: 15539105 Review.

9

Uptake of angiotensin II receptor blockers in the treatment of hypertension.

Greving JP, Denig P, van der Veen WJ, Beltman FW, Sturkenboom MC, de Zeeuw D, Haaijer-Ruskamp FM. Greving JP, et al. Among authors: de zeeuw d. Eur J Clin Pharmacol. 2005 Jul;61(5-6):461-6. doi: 10.1007/s00228-005-0924-7. Epub 2005 May 24. Eur J Clin Pharmacol. 2005. PMID: 15912393

10

The kidney, a cardiovascular risk marker, and a new target for therapy.

de Zeeuw D, Hillege HL, de Jong PE. de Zeeuw D, et al. Among authors: de jong pe. Kidney Int Suppl. 2005 Sep;(98):S25-9. doi: 10.1111/j.1523-1755.2005.09805.x. Kidney Int Suppl. 2005. PMID: 16108967 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

659 results

Search Page

Filters